AC Immune SA (NASDAQ:ACIU) went up by 10.90% from its latest closing price compared to the recent 1-year high of $13.00. The company’s stock price has collected 20.49% of gains in the last five trading sessions. Press Release reported on 12/15/20 that AC Immune Receives Competitive Target ALS Foundation Grant to Accelerate the Development of Proprietary Phosphorylated TDP-43 Immuno-assay
Is It Worth Investing in AC Immune SA (NASDAQ :ACIU) Right Now?
Plus, the 36-month beta value for ACIU is at 0.81. Opinions of the stock are interesting as 3 analysts out of 4 who provided ratings for AC Immune SA declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $10.12. ACIU currently public float of 37.91M and currently shorts hold a 3.38% ratio of that float. Today, the average trading volume of ACIU was 302.99K shares.
ACIU’s Market Performance
ACIU stocks went up by 20.49% for the week, with a monthly jump of 30.55% and a quarterly performance of 24.95%, while its annual performance rate touched -31.08%. The volatility ratio for the week stands at 8.60% while the volatility levels for the past 30 days are set at 5.48% for AC Immune SA. The simple moving average for the period of the last 20 days is 19.81% for ACIU stocks with a simple moving average of -1.29% for the last 200 days.
Analysts’ Opinion of ACIU
H.C. Wainwright gave a rating of “Buy” to ACIU, setting the target price at $18 in the report published on April 05th of the previous year.
ACIU Trading at 22.56% from the 50-Day Moving Average
After a stumble in the market that brought ACIU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -50.69% of loss for the given period.
Volatility was left at 5.48%, however, over the last 30 days, the volatility rate increased by 8.60%, as shares surge +29.23% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +36.97% upper at present.
During the last 5 trading sessions, ACIU rose by +20.49%, which changed the moving average for the period of 200-days by -3.46% in comparison to the 20-day moving average, which settled at $5.42. In addition, AC Immune SA saw 23.98% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ACIU
Current profitability levels for the company are sitting at:
- +40.11 for the present operating margin
The net margin for AC Immune SA stands at +40.93. The total capital return value is set at 19.27, while invested capital returns managed to touch 19.73. Equity return is now at value -24.20, with -22.10 for asset returns.
Based on AC Immune SA (ACIU), the company’s capital structure generated 1.07 points at debt to equity in total, while total debt to capital is 1.06. Total debt to assets is 0.97, with long-term debt to equity ratio resting at 0.67. Finally, the long-term debt to capital ratio is 0.66.
When we switch over and look at the enterprise to sales, we see a ratio of 2.78, with the company’s debt to enterprise value settled at 0.01. The receivables turnover for the company is 39.86 and the total asset turnover is 0.44. The liquidity ratio also appears to be rather interesting for investors as it stands at 16.72.